本页面由Tiger Trade Technology Pte. Ltd.提供服务

Apellis Pharmaceuticals Inc.

21.97
-0.3400-1.52%
成交量:2.29万
成交额:50.89万
市值:27.80亿
市盈率:61.34
高:22.38
开:22.23
低:21.97
收:22.31
52周最高:30.48
52周最低:16.10
股本:1.27亿
流通股本:7,811.99万
量比:0.50
换手率:0.03%
股息:- -
股息率:- -
每股收益(TTM):0.3581
每股收益(LYR):-1.5970
净资产收益率:14.10%
总资产收益率:5.13%
市净率:6.93
市盈率(LYR):-13.76

数据加载中...

2026/02/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/22

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/20

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/01/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities